|Articles|January 1, 2016
- BioPharm International-01-01-2016
- Volume 29
- Issue 1
BioPharm International, January 2016 Issue (PDF)
Click the title above to open the BioPharm International January 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Tools for Continuous Bioprocess Developmentabout 10 years ago
Framing Biopharma Success in 2016about 10 years ago
Going Small to Achieve Success on the Commercial Scaleabout 10 years ago
Politics and Pricing Will Challenge Manufacturers in 2016about 10 years ago
Serialization: Getting Past the Quick Fixabout 10 years ago
EMA Guideline on Setting Health-Based Exposure Limitsabout 10 years ago
Outsourcing Outlook for 2016about 10 years ago
Managing Market Expansion’s Effect on ProceduresNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Insuring Novel Biologic Development Against Geopolitical Developments: Part Three of Three with Abzena
2
Year in Review: How FDA Guidances Defined the 2025 Biopharma Landscape
3
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
4
Conjugation and Regulation Challenges for Advanced Molecules: Part Two of Three with Abzena
5
